🇺🇸 BRIGHT MINDS BIOSCIENCES INC.DRUG
Get BRIGHT MINDS BIOSCIENCES INC. filings on Telegram the moment they are published.
Follow BRIGHT MINDS BIOSCIENCES INC. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The FDA placed a partial clinical hold on the planned Phase 2 BMB-101 trial for Developmental and Epileptic Encephalopathies due to toxicity concerns.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest